Interim results to 31 December were in line with the 10 January trading statement, with revenues falling 7% to £3.9m, resulting in a pre-tax loss of £0.4m and period-end cash of £0.7m. Whilst no announcement of an initial purchase order from Boots is included within the interim statement, preparations for a mid-March retail launch are fully underway, with shelf space already allocated in some of the 1,305 stores. We use this opportunity to make changes to our forecasts, redu
21 Feb 2019
InnovaDerma - Interims – better H2 expected, driven by new launches
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
InnovaDerma - Interims – better H2 expected, driven by new launches
- Published:
21 Feb 2019 -
Author:
Mark Brewer -
Pages:
8
Interim results to 31 December were in line with the 10 January trading statement, with revenues falling 7% to £3.9m, resulting in a pre-tax loss of £0.4m and period-end cash of £0.7m. Whilst no announcement of an initial purchase order from Boots is included within the interim statement, preparations for a mid-March retail launch are fully underway, with shelf space already allocated in some of the 1,305 stores. We use this opportunity to make changes to our forecasts, redu